Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis

NCT03854851 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT03854851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03854851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis
Lead sponsor
China Medical University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2019
Completion date
October 31, 2019
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain